SCHEMBL6565679

SCHEMBL6565679

C=CCN(N)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL87764 0.81
SCHEMBL5438295 0.78
Hydrochloric Acid SCHEMBL27711738 0.78 ALDH1A1 (0.35)
Hydrochloric Acid SCHEMBL10636902 0.78
Bromide SCHEMBL9820146 0.78
Hydrochloric Acid SCHEMBL16568824 0.75 ALDH1A1 (0.33)
Propene SCHEMBL10414892 0.75
Cyclopropane SCHEMBL5845656 0.73 ALDH1A1 (0.32)
SCHEMBL370117 0.72 TSHR (0.41)
SCHEMBL4095968 0.72 TSHR (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111671767-B Proton-binding polymers for oral administration 特里赛达公司 2024-03-08 CN claimed
US-9993500-B2 Proton-binding polymers for oral administration TRICIDA, INC. (US) 2018-06-12 US claimed
US-9205107-B2 Proton-binding polymers for oral administration TRICIDA, INC. (US) 2015-12-08 US claimed
EP-3718551-B1 PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION RENOSIS INC (US) 2026-02-04 EP disclosed
EP-3812761-B1 PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION RENOSIS INC (US) 2025-12-24 EP disclosed
US-20250222021-A1 METHOD OF TREATING ACID-BASE DISORDERS RENIBUS THERAPEUTICS, INC. 2025-07-10 US disclosed
US-20250025494-A1 COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS RENIBUS THERAPEUTICS, INC. 2025-01-23 US disclosed
US-20250009785-A1 HCL-BINDING COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS RENIBUS THERAPEUTICS, INC. 2025-01-09 US disclosed
US-11992501-B2 Compositions for and methods of treating acid-base disorders RENOSIS, INC. (US) 2024-05-28 US disclosed
US-11986490-B2 Compositions for and method of treating acid-base disorders RENOSIS, INC. (US) 2024-05-21 US disclosed
US-20230405043-A1 PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION RENIBUS THERAPEUTICS, INC. 2023-12-21 US disclosed
CN-101175470-A Parakeratosis inhibitor, pore-shrinking agent and external composition for skin SHISEIDO CO LTD (JP) 2008-05-07 CN disclosed
EP-0879840-B2 Organopolysiloxanes containing polyhydroxyorganyl groups, especially sugar or sugar derivative groups, and polyoxyalkylene groups GOLDSCHMIDT AG TH (DE) 2004-03-31 EP disclosed
EP-0879840-B1 Organopolysiloxanes containing polyhydroxyorganyl groups, especially sugar or sugar derivative groups, and polyoxyalkylene groups GOLDSCHMIDT AG TH (DE) 2001-03-14 EP disclosed
EP-0857065-B1 USE OF 2-AMINO-4-(4-FLUOROBENZYLAMINO)-1-ETHOXY-CARBONYLAMINOBENZENE FOR PROPHYLAXIS AND TREATMENT OF SEQUELAE OF ACUTE AND CHRONIC REDUCED CIRCULATION IN THE BRAIN AND NEURODEGENERATIVE DISORDERS ASTA MEDICA AG (DE) 1999-04-07 EP disclosed
EP-0879840-A2 Organopolysiloxanes containing polyhhydroxyorganyl groups, especially sugar or sugar derivative groups , and polyoxyalkylene groups Th. Goldschmidt AG (DE) 1998-11-25 EP disclosed
EP-0525782-B1 Process for the preparation of functionalised diphenylsiloxane-dimethylsiloxane copolymers DOW CORNING TORAY SILICONE (JP) 1996-09-04 EP disclosed
US-5223596-A DIPHENYSILOXANE-DIMETHYLSIOXANE COPOLYMER AND METHOD FOR THE PREPARATION THEREOF DOW CORNING TORAY SILICONE CO., LTD. (JP) 1993-06-29 US disclosed
EP-0525782-A1 Process for the preparation of functionalised diphenylsiloxane-dimethylsiloxane copolymers Dow Corning Toray Silicone Company, Limited (JP) 1993-02-03 EP disclosed
US-5167947-A Enhancement of absorption of radioprotective drugs SOUTHWEST RESEARCH INSTITUTE (US) 1992-12-01 US disclosed